HawkCell
- 12/03/2024
- Series A
- $5,465,970
We are HawkCell, and we act now.
We're on a mission to make the healthcare industry more efficient and sustainable. We do this one animal MRI image at a time with a patented plug-and-play solution turning human MRI into an animal-dedicated one for veterinary clinics and preclinical research labs.
We're a young company, but we're well on our way to becoming the undisputed leader in animal imaging. After consolidating our presence in Europe, we have the ambition to expand rapidly to the United States and Asia and become the undisputed leader of MRI for animals. Today, HawkCell is the only player offering augmented MRI solutions with strategic partnerships with the leading MRI manufacturers. In 2022, our playing field is a serviceable obtainable market (SOM) evaluated at 700 million USD… a market growing at double digits YoY.
We believe there's a better way to do healthcare, better for everyone — animals and humans.
Visit our website www.hawkcell.com and join us in our ambitious mission.
- Industry Research Services
- Website https://hawkcell.com/
- LinkedIn https://www.linkedin.com/company/hawkcell/
Related People
Alexis GirinFounder
Alexis supports Large Groups, Private Equity and Venture Capital firms active in Digital & Deep Tech to accelerate their business overseas and bring their new business companies to the next level. Passionate by Disruptive Technologies and their positive impact on industries and people’s lives; Alexis often took minority participation in the Companies he developed being fully vested in his quest to success.
Alexis has served in different executive positions in IT, e-Commerce, Artificial Intelligence and Satellite Communication for high growth technology corporations owned by Private Equities. Used to manage complex multi-million dollars partnerships, Alexis is a visionary, fast paced leader who defines ambitious accurate go-to-market strategies, leverages on his negotiation expertise gained over the past two decades and large C-Level Network.
As CEO of a promising start up in MedTech he is building a plan to regionalise a unique MRI technology internationally and have an impact on pharmaceuticals and veterinarians.
His ability to raise and leverage funds from scratch, set-up entrepreneurial / transversal global units and evangelize new products in emerging markets with full management latitude is proven. Some of his key achievements include:
• The highest revenue growth in APAC with a seven times ROI post LBO;
• The raise of 250M$ funding from PEs to develop a revolutionary Revenue Management System (RMS) adopted by flagship companies.
Driven by the motto "We Do What We Say" and "We build Trust at C-Level", Alexis is passionate to bring disruptive solution to the market that will help our society to a more sustainable world.
Alexis holds an MBA and an Engineering Degree from L’Ecole des Ponts et Chaussées in Paris, France. From a multicultural background (French / Japanese), he had executive roles in all part of the globe, spending the last 10 years in APAC. Alexis defines himself as a "Citizen of the World".
He is married with four children and is an accomplished Ironman Triathlete with 3 participations to Ironman 70.3 World Championships. His favorite quote is “Anything is Possible with Focus, Determination, and Excellent Talents Harmony”.